Cargando…
Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapy
OBJECTIVE: Candida esophagitis belongs to the most common AIDS-defining diseases; however, a comprehensive immune pathogenic concept is lacking. DESIGN: We investigated the immune status of 37 HIV-1-infected patients from the Swiss HIV cohort study at diagnosis of Candida esophagitis, 1 year before,...
Autores principales: | Stuehler, Claudia, Bernardini, Claudia, Elzi, Luigia, Stoeckle, Marcel, Zimmerli, Stefan, Furrer, Hansjakob, Günthard, Huldrych F., Leibundgut-Landmann, Salomé, Battegay, Manuel, Khanna, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949004/ https://www.ncbi.nlm.nih.gov/pubmed/27149086 http://dx.doi.org/10.1097/QAD.0000000000001126 |
Ejemplares similares
-
Adverse events of raltegravir and dolutegravir
por: Elzi, Luigia, et al.
Publicado: (2017) -
Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition
por: Mossdorf, Erik, et al.
Publicado: (2011) -
A Comparison of Initial Antiretroviral Therapy in the Swiss HIV Cohort Study and the Recommendations of the International AIDS Society-USA
por: Wandeler, Gilles, et al.
Publicado: (2011) -
Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort Study
por: Elzi, Luigia, et al.
Publicado: (2016) -
AIDS defining opportunistic infections in patients with high CD4 counts in the combination antiretroviral therapy (cART) era: things ain't what they used to be
por: Gisler, Valentin, et al.
Publicado: (2014)